GlassScriptPhysician profile
Malcolm T Foster
NPI 1861482556
$413,287.42
in general payments reported to CMS, 2019-2025
74 companies · $90K in 2025
The $90K reported for 2025 was more than what 98% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53K · 2020: $36K · 2021: $35K · 2022: $55K · 2023: $57K · 2024: $87K · 2025: $90K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $85K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $59K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $40K · Travel and Lodging: $28K · Food and Beverage: $20K · Education: $96.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $85,462.50 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $59,450.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $40,115.50 |
| Travel and Lodging | $28,499.96 |
| Food and Beverage | $20,280.54 |
| Education | $96.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $95,346.50 | 2019-2025 | Xact, Optis, Amplatzer Talisman |
| Shockwave Medical, INC | $85,723.05 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $51,286.19 | 2019-2025 | Indigo System, Ruby Coil |
| Amgen INC. | $39,609.96 | 2019-2025 | Repatha, Repatha |
| Amarin Pharma, INC. | $38,404.92 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $29,263.92 | 2019-2023 | Xarelto |
| Angiodynamics, INC. | $19,431.88 | 2021-2025 | Alphavac, Angiovac, Nanoknife |
| Astrazeneca Pharmaceuticals LP | $18,523.70 | 2019-2025 | Brilinta, Farxiga, Wainua |
| Esperion Therapeutics, INC. | $16,423.91 | 2020-2025 | Nexletol |
| Boston Scientific Corporation | $2,871.03 | 2019-2025 | Watchman Flx, Avvigo Guidance System, Watchman |
| Ancora Heart, INC. | $2,862.69 | 2023-2025 | Accucinch |
| Merit Medical Systems INC | $2,849.07 | 2019-2022 | |
| Abiomed | $1,556.31 | 2019-2023 | Impella |
| Novartis Pharmaceuticals Corporation | $1,147.77 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,145.12 | 2019-2025 | Lifevest |
Show all 63 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $793.47 | 2019-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Heartflow, INC. | $727.13 | 2023-2025 | Ffrct |
| Silk Road Medical, INC. | $530.23 | 2022-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Pfizer INC. | $527.55 | 2019-2025 | |
| Cvrx, INC. | $365.13 | 2023-2025 | Barostim Neo System |
| Medtronic, INC. | $348.71 | 2021-2025 | Acist Rxi System, Hawkone, Abre |
| Philips North America LLC | $322.06 | 2022-2025 | (Ck4) Mcot, Coronary Other |
| E.R. Squibb & Sons, L.L.C. | $302.97 | 2019-2025 | Camzyos, Eliquis |
| Novo Nordisk INC | $290.78 | 2019-2025 | Ozempic, Rybelsus |
| Atricure, INC. | $284.76 | 2024 | |
| Cardiovascular Systems INC. | $255.65 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $192.64 | 2020-2024 | Jardiance |
| Imperative Care, INC | $174.94 | 2024 | Symphony Catheter |
| Biosense Webster, INC. | $164.02 | 2024-2025 | Carto 3 |
| Ablative Solutions, INC. | $125.46 | 2020-2023 | |
| Scpharmaceuticals INC. | $99.24 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $93.25 | 2022-2023 | Verquvo |
| Regeneron Healthcare Solutions, INC. | $85.57 | 2019-2025 | Evkeeza |
| Cardinal Health 200 LLC | $81.37 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $76.95 | 2024 | Arcalyst |
| Medtronic Vascular, INC. | $75.14 | 2019 | |
| Astellas Pharma US INC | $75.00 | 2019 | |
| Baxter Healthcare | $72.05 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Cardiva Medical, INC. | $71.41 | 2024-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade Mvp Vvcs 6-12f |
| Sanofi-Aventis U.S. LLC | $68.40 | 2019-2022 | |
| Edwards Lifesciences Corporation | $54.61 | 2020-2025 | Sapien 3 Ultra Resilia |
| Actelion Pharmaceuticals US, INC. | $51.80 | 2019-2023 | Uptravi, Opsumit |
| Celonova Biosciences, INC. | $49.32 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $48.57 | 2022-2025 | |
| Preventice Services, LLC | $47.75 | 2021 | |
| Teleflex LLC | $37.75 | 2024 | Guideliner |
| Endovascular Engineering INC. | $37.57 | 2024-2025 | Helo Thrombectomy System |
| Janssen Scientific Affairs, LLC | $30.71 | 2022 | |
| Ge Healthcare | $29.86 | 2022 | |
| Thrombolex, INC. | $25.70 | 2025 | Bashir Endovascular Catheter |
| Lexicon Pharmaceuticals, INC. | $25.09 | 2023 | Inpefa |
| W. L. Gore & Associates, INC. | $24.59 | 2023 | Gore Cardioform Septal Occluder |
| Ethicon US, LLC | $22.42 | 2024 | Vistaseal, Stratafix |
| Daiichi Sankyo INC. | $20.86 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $17.96 | 2023 | Arcalyst |
| Biotronik INC. | $16.86 | 2019 | |
| Arbor Pharmaceuticals, INC. | $15.56 | 2019 | |
| Convatec INC. | $15.42 | 2019 | |
| Gilead Sciences, INC. | $14.49 | 2019 | |
| Shield Therapeutics INC | $13.56 | 2024 | |
| G Medical Diagnostic Services, INC. | $13.10 | 2024 | Cardiac Monitoring Suite |
| Kowa Pharmaceuticals America, INC. | $12.61 | 2020 | |
| Irhythm Technologies, INC. | $11.36 | 2019 |
11 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Malcolm Foster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.